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Virulent Salmonella enterica infections can be exacerbated by
concomitant infection of the host with a live attenuated S. enterica
vaccine via Toll-like receptor 4-dependent interleukin-10 production
with the involvement of both TRIF and MyD88
Introduction
Salmonella enterica causes enteric fever, gastroenteritis and
septicaemia in humans worldwide. The S. enterica serovar
Typhi causes approximately 22 million cases of typhoid
fever and over 200 000 deaths annually; serovar paratyphi
causes about 55 million illnesses in humans.1 Other non-
typhoidal Salmonella serotypes (e.g. Typhimurium,
enteritidis) cause gastroenteritis in humans and animals
and can spread via contaminated food, which is a major
concern for the food industry. Non-typhoidal Salmonella
are a common cause of bacteraemia and sepsis in immuno-
compromised individuals (e.g. patients with human
immunodeficiency virus infection or malaria) and in chil-
dren, especially in developing countries where they consti-
tute a major cause of death.2–13 The control of S. enterica
infections is challenging because of the emergence of
multi-drug-resistant S. enterica strains, the insufficient effi-
cacy of currently licensed vaccines and the lack of effective
vaccines against non-typhoidal Salmonella infections.14
Single-dose live attenuated oral vaccines, such as the aroC
ssaV Typhi strain, are currently being developed.15
Prevention and treatment of S. enterica infections will
benefit from a clearer understanding of the location and
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Summary
During systemic disease in mice, Salmonella enterica grows intracellularly
within discrete foci of infection in the spleen and liver. In concomitant
infections, foci containing different S. enterica strains are spatially sepa-
rated. We have investigated whether functional interactions between bac-
terial populations within the same host can occur despite the known
spatial separation of the foci and independence of growth of salmonellae
residing in different foci. In this study we have demonstrated that bacte-
rial numbers of virulent S. enterica serovar Typhimurium C5 strain in
mouse tissues can be increased by the presence of the attenuated aroA
S. Typhimurium SL3261 vaccine strain in the same tissue. Disease exacer-
bation does not require simultaneous coinjection of the attenuated bacte-
ria. SL3261 can be administered up to 48 hr after or 24 hr before the
administration of C5 and still determine higher tissue numbers of the vir-
ulent bacteria. This indicates that intravenous administration of a S. ent-
erica vaccine strain could potentially exacerbate an established infection
with wild-type bacteria. These data also suggest that the severity of an
infection with a virulent S. enterica strain can be increased by the prior
administration of a live attenuated vaccine strain if infection occurs
within 48 hr of vaccination. Exacerbation of the growth of C5 requires
Toll-like receptor 4-dependent interleukin-10 production with the involve-
ment of both Toll/interleukin-1 receptor-domain-containing adaptor
inducing interferon-b and myeloid differentiation factor 88.
Keywords: exacerbation; immunity; infection; interleukin-10; myeloid
differentiation factor 88; Salmonella; Toll/interleukin-1 receptor-domain-
containing adaptor inducing interferon-b; Toll-like receptor 4
 2008 Blackwell Publishing Ltd, Immunology, 124, 469–479 469
IMMUNOLOGY OR IG INAL ART ICLE
dynamics of spread and distribution of individual bacte-
rial populations within the host and from the knowledge
of how individual bacteria interact with each other during
infection.
In murine models of systemic infection S. enterica ini-
tially reside mainly within resident phagocytes of the
spleen and liver16–20 and subsequently within inflamma-
tory phagocytes that are recruited to multicellular foci
of infection and are activated via the production of
proinflammatory cytokines.21–33 Microscopic observation
of individual bacteria in infected cells has revealed that
the ability of S. enterica to disseminate within the tis-
sues is an important trait of virulent bacteria in addi-
tion to their ability to grow intracellularly and resist
killing by phagocytes.34,35 The in vivo growth of virulent
S. enterica is associated with the continuous spread of
bacteria in the tissues to form spatially independent
new infection foci, each containing low bacterial num-
bers. The number of foci increases in parallel with the
net bacterial growth rate of the infecting S. enterica
strain.34 The integration of mathematical models and
microscopic observations has generated testable predic-
tions on the parameters that govern bacterial growth
and spread with implications for pathogen dynamics,
evolution and control. Current modelling frameworks
indicate that spread of S. enterica within the liver is
governed by density-independent necrotic lysis of
infected phagocytes underlain by density-dependent
intracellular bacterial replication.35
These approaches have also revealed striking spatial and
functional independence between individual bacterial pop-
ulations within an infected animal. Different populations
or clones of S. enterica always segregate to individual foci
of infection and do not mix.34 Functional independence
between infection foci is illustrated by independent growth
rates and infection kinetics of S. enterica strains when
simultaneously inoculated into mice.36
The effects of host immune responses on different bac-
terial strains within the same host are also determined by
events that occur at the level of individual infection foci.
For example, in concurrent staggered infections, started
3 days apart with two S. enterica strains of similar viru-
lence, the growth curves of the two bacterial strains in the
tissues are comparable, but the suppression of bacterial
growth occurs independently for each strain.36 The events
leading to the control of one strain do not affect the
development of the concurrent infection. These observa-
tions are intriguing given the known essential role of sys-
temic mediators [e.g. interferon-c (IFN-c) and tumour
necrosis factor-a] in the recruitment and activation of
phagocytes at the foci of infection.21,22,28,32,37,38 In sum-
mary, different bacterial populations segregate spatially
within the same host and local immunological events that
occur at the level of each focus of infection affect differ-
entially and independently each bacterial population
despite the additional necessary contribution of the sys-
temic immune response.
It is still unclear whether situations exist where simulta-
neous infections can affect one another via signals that
are independently generated in spatially separated phago-
cytes or infection foci. It has previously been suggested
that infected cells may be capable of globally conditioning
uninfected phagocyte populations within the host. In fact,
parenteral administration of dead Gram-negative bacteria
or lipopolysaccharide (LPS) can been shown to exacerbate
the growth of virulent S. enterica in mice39 and can cause
the resurgence of typhoid fever in asymptomatic typhoid
carriers,40 but the mechanisms underlying these phenom-
ena are largely unknown. Testing the possibility that
infected cells can affect cohorts of infected and/or non-
infected cells within the same host, and understanding
the mechanisms that regulate these interactions, have
important implications for understanding how bacteria
interact at the local level within the host tissues and for
predicting the possible consequences of interactions
between S. enterica vaccines and environmentally acquired
wild-type virulent organisms.
In the present paper we show that an attenuated
S. enterica strain can induce an increase in the splenic
and hepatic numbers of a virulent strain via early pro-
duction of interleukin-10 (IL-10). Serum levels of IL-10
were transient but exerted a lasting conditioning effect
on the global population of phagocytes in the spleen and
liver resulting in exacerbation of the growth of virulent
bacteria. The increase in the numbers of the virulent
strain seen in double infections did not require simulta-
neous coinjection of the attenuated bacteria because the
effect was still apparent when the two infections were
staggered. Toll-like receptor 4 (TLR4) signalling was
required for early IL-10 production. Both Toll/IL-1
receptor (TIR)-domain-containing adaptor inducing IFN-
b (TRIF) and myeloid differentiation factor 88 (MyD88)
could mediate TLR4-dependent IL-10 production with
optimal levels of IL-10 production requiring the presence
of both signalling molecules.
Materials and methods
Animals
C57BL/6 and BALB/c mice (both Sc11a1s) were purchased
from Harlan Olac Ltd (Bicester, UK). Mice that were
homozygous for mutations in TLR4 (TLR4)/))41 and
TRIF (TRIF)/))42 (backcrossed at least six times onto the
C57BL/6 background) were bred and housed in patho-
gen-free conditions at Harlan Ltd, UK or at the Depart-
ment of Veterinary Medicine, Cambridge. Mice that were
homozygous for mutations in MyD88 (MyD88)/))42,43 on
a C57BL/6 background were bred and housed at the Uni-
versity of Edinburgh. Mice with homozygous mutations
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in IL-10 (IL-10)/))44 were obtained from B&K Universal
(Hull, UK).
Bacteria
Salmonella Typhimurium C5 is a highly virulent bacterial
strain with a lethal dose for 50% (LD50) by the intra-
venous route of infection of < 10 colony-forming units
(CFU) in BALB/c mice.45 The S. Typhimurium SL3261
strain is an aroA attenuated derivative of S. Typhimurium
SL1344 with an intravenous LD50 for BALB/c mice of
approximately 107 CFU.46 Rifampicin-resistant SL3261
and nalidixic-acid-resistant C5 were generated by selec-
tion on media containing antibiotics. SL3261 were heat
killed by boiling for 10 min.
Inoculation of mice and enumeration of bacteria within
organ homogenates
Bacterial suspensions for injection were prepared from
single-colony cultures of 15 ml Luria–Bertani (LB) broth
incubated without shaking overnight at 37. Cultures
were diluted as appropriate in phosphate-buffered saline
and injected into a lateral tail vein. Inocula were enumer-
ated by pour-plating with LB agar supplemented with rif-
ampicin or nalidixic acid (Sigma, Poole, UK). The C5
strain was injected at 103 CFU per animal and SL3261
was injected at 106 CFU per animal. Mice were killed by
cervical dislocation and spleens and livers were aseptically
removed. Organs were placed into stomacher bags and
homogenized in 10 ml sterile water in a Colworth Stom-
acher 80. The resulting homogenate was 10-fold serially
diluted in phosphate-buffered saline and pour-plated with
LB agar supplemented with rifampicin (100 lg/ml) or
nalidixic acid (15 lg/ml) as appropriate.
Assay of serum IL-10
Blood was collected from a lateral tail vein, incubated for
90 min at room temperature and centrifuged at 12 000 g
for 10 min. The serum supernatant was split into aliquots
and stored at )80. Interleukin-10 was measured by Bio-
track enzyme-linked immunosorbent assay (ELISA; GE
Healthcare UK Ltd, Buckinghamshire, UK) according to
the manufacturer’s instructions.
Macrophage culture and stimulation
Mouse femurs were flushed with RPMI-1640 and the
resultant cells were grown at 37 in a 5% CO2 atmo-
sphere on bacteriological Petri dishes in 80% RPMI-1640
[supplemented with 10% heat-inactivated fetal calf serum,
2 mM L-glutamine, 005 mM 2-mercaptomethanol, 1 mM
sodium pyruvate, 5% horse serum (all reagents from
Sigma-Aldrich, UK)] with 20% medium supernatant from
L929 cells. After 7 days of culture, cells were detached by
scraping and replated in fresh medium at a density of
3 · 106 per plate for a further 7 days. For stimulation,
cells were scraped and plated at a density of 105 per well
in 96-well plates and incubated overnight. Culture med-
ium was removed and replaced with fresh medium con-
taining 1 lg/ml S. Minnesota LPS (Invivogen, Toulouse,
France) or heat-killed SL3261 (multiplicity of infection
10) and the cells were incubated at 37 in 5% CO2.
Supernatants were removed at the appropriate times and
frozen at )80. Interleukin-10 was measured by DuoSet
sandwich ELISA (R&D Systems Europe Ltd, Abingdon,
UK).
Statistics
To assess the difference in the growth rates between the
C5 single infection and the C5 and SL3261 double infec-
tions over time (Fig. 1a), a multiple linear regression
model was used. The data for the spleen and liver counts
were analysed separately, and when regressing log10(CFU)
against time the best fitting model was the one that had a
common intercept but different slopes (i.e. statistically
significantly different growth rates) for the alternative
infection types.
Multiple linear regression was also employed for all
other analyses in the paper. This allowed us to make
inferences about differences in the response variable
(C5 CFU or IL-10 serum production) across all groups
within one modelling framework, negating the need to
use any multiple adjustment procedures that arise from
traditional null hypothesis significance testing (such as
pairwise t-tests). Analysis of variance (ANOVA) was used to
compare the fits of two models, the first with genotype
and presence/absence of SL3261 as the main effects, and
the second with an additional interaction term between
these two factors. A statistically significant improvement
in the fit of the second model suggested that the effect of
double infection with SL3261 on the response variable in
the wild-type control mice was different when compared
to the corresponding effect in the gene-targeted animals.
The net result was that we could compare the difference
in rates of increase/decrease between single and double
infections in different genotypes by studying the corre-
sponding parameter estimate from the model (informa-
tion that we cannot obtain using null hypothesis testing
procedures).
Multiple repeats were also analysed and as a cautionary
measure we also reassessed the significance of the para-
meter estimates using non-parametric (usually bootstrap-
ping) techniques before reporting the results. This was to
ascertain possible non-normality of the data. Reported
significant results are those that both analyses (standard
and non-parametric) return as significant at the 5% level.
All data analysis was undertaken using the R statistical
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language (R Development core team, Vienna, Austria.
http://www.R-project.org), using the ‘boot’ library.47
Results
The administration of the attenuated S. enterica
SL3261 strain can increase the net growth rate of the
virulent S. enterica C5 strain within the same host
BALB/c mice were injected intravenously with combina-
tions of a low dose of virulent nalidixic-acid-resistant
S. enterica C5 bacteria with a larger dose of a rifampicin-
resistant S. enterica SL3261 attenuated strain. Parallel
groups of mice received either the C5 strain alone or the
SL3261 strain alone. The net bacterial growth rates of
both strains were followed in the spleens and livers of dif-
ferent groups of mice for a 96-hr period. In all cases, the
numbers of viable S. enterica SL3261 remained between
105 and 106 throughout the observation period fluctuat-
ing only minimally (not shown). In mice receiving C5
alone, a net increase in numbers of bacteria of about 10-
fold per day was observed (Fig. 1a). Linear regression
analysis was used to evaluate the differences in growth
rate of the C5 strain between single and double infections.
This showed that there were statistically significant differ-
ences in the rates of C5 growth between the single and
double infections in both the spleen (P < 00001) and
liver (P < 00001). Thus, coadministration of S. enterica
SL3261 with C5 resulted in higher bacterial loads in the
later stages of the infection (Fig. 1a).
The higher bacterial loads of C5 were dependent on the
dosage of strain SL3261 (Fig. 1b). The strongest exacerba-
tion of the C5 infection was observed when it was simul-
taneously administered with 107 CFU of SL3261, while
negligible exacerbation was seen for the 104 dosage in
C57BL/6 mice. It is noteworthy that the intermediate
dosages of 105 and 106 CFU, which are routinely used
for parenteral vaccination of mice when testing the
immunogenicity of live attenuated vaccine strains,
induced a statistically significant increase in numbers of
C5 (Fig. 1b).
Administration of S. enterica SL3261 can increase the
severity of the infection with the virulent S. enterica
C5 strain in staggered infections
To investigate whether the higher bacterial numbers of C5
seen in double infections were dependent on the simulta-
neous administration of SL3261, the two strains were
administered to the same mice but the infections were stag-
gered by 24 or 48 hr. Figure 2(a) suggests that administra-
tion of SL3261 to mice carrying an already established C5
infection resulted in an increase in the growth of C5, lead-
ing to higher bacterial numbers in the tissues at the 96-hr
time point [this result was highly significant when tested
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Figure 1. Exacerbation of Salmonella enterica serovar Typhimurium
C5 viable counts caused by coadministration of S. enterica serovar
Typhimurium SL3261. (a) Wild-type (WT) BALB/c mice were
infected intravenously (i.v.) with 103 colony-forming units (CFU) of
virulent C5 (single infections, s and D). Another group of wild-type
BALB/c mice was infected i.v. with 103 CFU virulent C5 together
with 1 · 106 CFU S. enterica serovar Typhimurium SL3261 (double
infections, d and m). Spleen (circles, dotted lines) and liver (trian-
gles, solid lines) counts of viable bacteria were obtained at times
thereafter by plating organ homogenates on selective media (see
Materials and methods). The results are expressed as mean
log10 CFU ± standard deviation from groups of three mice per
point. Rates of C5 growth in C5 single and C5 double infections
were compared by linear regression analysis. *Significance at
P < 005 for difference in rates of C5 growth in the spleen. ¤Signifi-
cance at P < 005 for differences in rates of C5 growth in the liver.
(b) Groups of five wild-type C57BL/6 mice were infected i.v. with
103 CFU of virulent C5 (C5 only), or with the same dose of C5
together with 107, 106, 105 or 104 CFU of SL3261. Three days later,
viable bacterial counts in livers and spleens were assayed. For brevity,
viable counts for spleen are shown but equivalent results were
observed in the liver. The results are expressed as mean
log10 CFU ± standard deviation. *P < 005 when comparing the
double infected groups to the single C5-only group.
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using multiple regression but was borderline (P = 008)
when using Mann–Whitney (Holm-adjusted) pairwise
comparisons – see Materials and methods]. Injection of C5
24 hr after the administration of SL3261 also resulted in
increased growth of the virulent bacteria (Fig. 2b). Interest-
ingly, the presence of a pre-existing SL3261 infection for
48 hr resulted in a lower bacterial growth rate of the C5
strain compared to the single C5 infection. The data
suggest that the exacerbation of the C5 infection does not
require simultaneous administration of SL3261.
IL-10 contributes to the exacerbation of the growth
of S. enterica C5 induced by coadministration of
S. enterica SL3261
In search of a systemic mechanism that might be responsi-
ble for the suppression of macrophage functions we inves-
tigated the possibility that immunosuppressant soluble
factors could account for a global downregulation of
phagocyte functions that would result in exacerbated infec-
tion with the virulent C5 strain. Both IL-10)/) mice and
congenic C57BL/6 control mice were infected either with
C5 alone (single infections) or with a combination of C5
and SL3261 (double infections). An increase in tissue
numbers of C5 as a result of double infections was seen in
both the spleens and livers of C57BL/6 and IL-10)/) mice
at day 3 postinfection (Fig. 3). There was no evidence to
suggest that the C5 viable counts differed significantly
between C57BL/6 and IL-10)/) mice in single infections.
We also found that there was a significant interaction
effect between mouse genotype and the presence or
absence of the SL3261 strain. Moreover this effect was neg-
ative. This suggests that although coinfection with C5 and
SL3261 resulted in increased growth of C5 bacteria in both
C5
 S
.
 
Ty
ph
im
u
riu
m
/o
rg
an
 (lo
g 1
0 
CF
U)
7 
×30·5 
* 
* 
* 
* 
×36·8 
×5·2 
×5·1 
6 
5 
4 
WT 
single 
IL-10–/– 
single 
WT 
double 
IL-10–/– 
double 
6·5 
5·5 
4·5 
Figure 3. Growth of C5 in wild-type (WT) and interleukin-10
deficient (IL-10)/)) mice. Both IL-10)/) mice and wild-type C57BL/6
mice were infected with 103 colony-forming units (CFU) of C5 (sin-
gle infections) or double infections with 103 CFU of C5 combined
with 106 CFU of SL3261. Spleen (solid bars) and liver (open bars)
counts of C5 were determined at 3 days postinfection. The results
are expressed as mean log10 CFU ± standard deviation of four mice
per data point. *P < 005 when comparing the double infected group
to the single C5-only group for each mouse genotype.
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Figure 2. Salmonella Typhimurium SL3261 can cause acceleration in
the C5 growth rate even if not administered simultaneously.
(a) Wild-type (WT) C57BL/6 mice were infected intravenously (i.v.)
with 103 colony-forming units (CFU) of virulent C5 at time 0 (s).
Three further groups of wild-type C57BL/6 mice were all given
103 CFU of virulent C5 at time 0 and then given 106 CFU SL3261 at
0 hr (d), 24 hr (n) or 48 hr (m). Viable bacterial counts were
obtained from spleens 24 hr after SL3261 infection and then at
96 hr. Mice in the C5-only group were assayed for viable bacterial
counts at 24 and 96 hr postinfection. The results are expressed as
mean log10 CFU ± standard deviation for four mice per point.
(b) Wild-type C57BL/6 mice were infected i.v. with 103 CFU of viru-
lent C5 at time 0 (s). Three further groups of wild-type C57BL/6
mice were given 106 CFU of SL3261 at time 0 and then given
103 CFU of C5 at 0 hr (d), 24 hr (n) or 48 hr (m). Viable bacterial
counts were obtained from the spleen at 24 hr after C5 infection and
then at 96 or 120 hr. The C5-only group was assayed for viable bac-
terial counts at 24 and 96 hr postinfection. The results are expressed
as mean log10 CFU ± standard deviation of four mice per point. For
brevity, viable counts for spleen are shown but equivalent results
were observed in the liver.
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C57BL/6 and IL-10)/) mice, the rate of increase was
reduced when IL-10 was absent. The net result of this was
that the mean increase in log10 C5 viable counts seen in
the IL-10)/) mice as a result of double infection was much
reduced (· 52 in livers, · 51 in spleens) as compared to
the increase seen in wild-type C57BL/6 mice (· 368 in
livers, · 305 in spleens). These data suggest that IL-10 is
an important mediator of the higher tissue numbers of C5
seen after coadministration of SL3261.
In vivo production of IL-10 is transient and TLR4
dependent
To determine the kinetics of IL-10 release, groups of five
C57BL/6 mice undergoing single and double infections
were bled 1 hr after administration of the bacteria and
IL-10 was measured in the sera by ELISA. The IL-10 was
detected in the sera of mice simultaneously infected with
both the C5 and the SL3261 strains (982 ± 405 pg/ml),
but not in mice injected with the C5 strain only (limit of
detection 188 pg/ml). Levels of IL-10 were highest at 1 hr
postinfection, IL-10 was still detectable at lower levels in
some animals at 5 hr but was absent from the sera of all
mice by 24 hr postinfection. Levels of IL-10 in mice
injected with SL3261 alone were similar to those seen in
the sera of mice undergoing double infections (unpub-
lished data). Thus, an early transient peak of IL-10 was
seen in double infections in C57BL/6 mice.
To examine the mechanism of early IL-10 serum release
in vivo, groups of five C57BL/6 and TLR4)/) mice were
injected with C5 alone or with C5 and SL3261 together.
No IL-10 was detected in the sera of TLR4)/) mice (limit
of detection 188 pg/ml). Similarly, TLR4)/) mice infected
with SL3261 alone did not produce detectable amounts of
IL-10. Early IL-10 production was entirely dependent
upon TLR4 signalling.
The higher tissue numbers of the virulent C5 strain
seen after coadministration of the SL3261 strain
depend upon LPS responsiveness
Administration of a large bolus of dead bacteria
(108 CFU/animal) or purified LPS can accelerate the
growth rate of virulent S. enterica in mice, the effect
depending on LPS responsiveness.39 So far we have shown
that IL-10 greatly contributes to the higher tissue num-
bers of the C5 strain seen after coadministration of
SL3261 and that IL-10 production is dependent on the
presence of functional TLR4. To assess whether TLR4 was
involved in the SL3261-dependent disease exacerbation,
we performed single and double infections in TLR4)/)
mice and monitored the bacterial burden in spleens and
livers at 24-hr intervals for 3 days.
Figure 4 shows the viable C5 counts on day 3 postin-
fection in C57BL/6 and TLR4)/) mice in the liver and
spleen. The results indicate that there was a significant
difference (P < 005) in the log10 CFU count between
C57BL/6 and TLR4)/) mice in single infections of S. ent-
erica C5. Moreover, this effect was positive, suggesting
that the presence of TLR4 inhibited growth of C5 single
infections. There was evidence that double infections of
C5 with SL3261 exacerbated growth of C5 in C57BL/6
mice but the effect of the double infection in TLR4)/)
mice was negligible. TLR4 and presumably LPS signalling
are therefore required for the exacerbation of the growth
of C5 in C57BL/6 mice. The numbers of viable SL3261
were similar in C57BL/6 and TLR4)/) mice up to day 3
postinfection (unpublished data).
TLR4-dependent and TLR4-independent signalling
pathways involving both MyD88 and TRIF contribute
to IL-10 production from bone marrow derived
macrophages
To dissect the signalling pathways that lead to IL-10 pro-
duction in response to S. enterica LPS and to whole
S. enterica bacterial cells, we used in vitro cultures of
bone-marrow-derived macrophages (BMDM) from
C57BL/6 mice, from TLR4)/) mice and from mice defi-
cient in the adaptor proteins TRIF and MyD88, which
could potentially be involved in TLR4-dependent IL-10
production.48 TRIF and MyD88 form two separate signal-
ling pathways originating from TLR4. Recruitment of
MyD88 to TLR4 leads to the activation of nuclear factor-
jB and the mitogen-activated protein kinases p38 and
JNK resulting in proinflammatory cytokine production.
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Figure 4. Toll-like receptor 4 (TLR4) plays an important role in
exacerbating the growth of C5 in the double infections. Both TLR4)/)
and wild-type (WT) C57BL/6 mice were infected with 103 colony-
forming units (CFU) of C5 (single infections) or double infections of
103 CFU of C5 combined with 106 CFU of SL3261. Spleen (solid
bars) and liver counts (open bars) were determined at day 3 post-
infection. The results are expressed as mean log10 CFU ± standard
deviation of five mice per group. *P < 005 when comparing the double
infected group to the single C5-only group for each mouse genotype.
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The TRIF pathway also results in late nuclear factor-jB
activation but additionally activates interferon response
factor-3 resulting in the production of type I interferon-
responsive genes.49
Macrophage cultures were exposed to LPS or whole
bacterial cells and IL-10 release was measured in the
supernatants at various times thereafter. The BMDM
from wild-type C57BL/6 mice, but not from TLR4)/)
mice, produced IL-10 in response to LPS with peak levels
reached after 8–12 hr. The BMDM from TRIF)/) and
MyD88)/) mice produced detectable levels of IL-10, indi-
cating that both of these signalling molecules can mediate
the LPS-induced release of IL-10. However, IL-10 release
from TRIF)/) and MyD88)/) BMDM was low compared
to that seen in cells from wild-type C57BL/6, indicating
that both TRIF and MyD88 are needed for optimal IL-10
production (Fig. 5a). Similar results were obtained when
stimulating BMDM with heat-killed S. enterica bacterial
cells except for the detectable level of IL-10 in the super-
natants of TLR4)/) BMDM (Fig. 5b), indicating that
receptors other than TLR4 also contribute to IL-10 release
from BMDM in response to S. enterica bacterial cells.
IL-10 production in response to S. enterica was mediated
by LPS recognition via TLR4 but may also involve other
signalling receptors. Both TRIF and MyD88 were suffi-
cient for IL-10 production by cells in culture in response
to S. enterica with optimal responses requiring the simul-
taneous presence of both of these signalling molecules.
Both MyD88 and TRIF contribute to IL-10
production in vivo
Both TRIF and MyD88 were involved in IL-10 produc-
tion from BMDM upon exposure to S. enterica so we
proceeded to study the relative contribution of these
adaptor molecules to the early in vivo release of IL-10
seen in the sera of mice undergoing double infections. As
expected, IL-10 was detectable in the sera of C57BL/6
mice injected with both S. enterica strain SL3261 and
strain C5 (Fig. 6a,b). Detectable levels of IL-10 were also
seen in the sera of both TRIF)/) and MyD88)/) mice
undergoing double infections, although the levels were
significantly reduced compared to those found in C57BL/
6 mice. In single C5 infections neither the mutant mice
nor the C57BL/6 mice produced detectable levels of IL-10
(Fig. 6a,b). Either signalling via TRIF or via MyD88 was
sufficient for in vivo IL-10 production, but the high levels
of IL-10 observed in C57BL/6 mice required both adaptor
molecules to be present.
Relative contribution of TRIF and MyD88 to the
increased net growth rate of virulent C5
We proceeded to assess the role of these adaptor mole-
cules in causing the higher tissue numbers of C5 observed
in double infections. As with TLR4)/) mice, lack of
MyD88 resulted in higher bacterial numbers in single C5
infections (Fig. 6c) and although double infections with
SL3261 exacerbated C5 growth in both C57BL/6 and
MyD88)/) mice, the relative increase was significantly less
in the latter case (shown by a significant negative inter-
action term between genotype and type of infection). Sta-
tistically significantly increased tissue numbers of C5 were
seen in the spleens and livers of TRIF)/) mice in double
infections. However, this time there was no evidence to
suggest that the degree of exacerbation of C5 growth in
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Figure 5. Interleukin-10 (IL-10) production induced by lipopoly-
saccharide (LPS) and heat-killed Salmonella enterica is MyD88 and
Toll/IL-1 receptor-domain-containing adaptor inducing interferon-b
(TRIF)-dependent. Bone-marrow-derived macrophages cultured
from wild-type (WT) C57BL/6, MyD88)/), Toll-like receptor 4 defi-
cient (TLR4)/)) and TRIF)/) mice were stimulated with either 1 lg/
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detection by enzyme-linked immunosorbent assay. The graphs are
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control [WT(TT)]. Data points represent the mean IL-10 produc-
tion ± standard deviation from three wells per time point, minus the
mean IL-10 production from the untreated wells.
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TRIF)/) mice as a result of coinfection with SL3261 was
different compared to C57BL/6 control mice (Fig. 6d).
The ability of TRIF and MyD88 to mediate the higher tis-
sue numbers of C5 seen in double infections was there-
fore consistent with the fact that either TRIF-dependent
or MyD88-dependent signalling pathways can mediate
production of IL-10 in response to S. enterica in vitro and
in vivo.
Discussion
The work presented in this paper shows that one bacterial
strain can influence the growth of another when these
strains are known to be living in spatially separate foci of
infection34 within the host via the release of systemic
mediators. The administration of an attenuated S. enterica
strain with limited ability to grow in the mouse tissues
produced a dramatic increase in tissue numbers of a viru-
lent S. enterica strain. The disease acceleration was depen-
dent upon the release of the immunosuppressive cytokine
IL-10. The study illustrates that IL-10 production in
response to S. enterica requires TLR4 and occurs via
signalling pathways involving both TRIF and MyD88
adaptor molecules.
A key feature of S. enterica infections is the spatial seg-
regation of different bacterial populations within the same
host. Individual bacterial clones grow in the animal tis-
sues and spread to form spatially independent new infec-
tion foci each containing low bacterial numbers.34 The
individual foci appear to be functionally independent as
shown by the fact that multiple S. enterica strains of dif-
ferent virulence retain their individual net growth profiles
even when administered to the same host in simultaneous
infections.36
We observed that the administration of an attenuated
strain, at an intermediate dose routinely used for paren-
teral vaccination of mice, can induce a significant acceler-
ation of disease progression with wild-type S. enterica
within the same host. These results indicate that there are
circumstances in which a set of infected cells (i.e. the
phagocyte recipients of the attenuated strain) can globally
influence the host immune system, resulting in the sup-
pression of the antibacterial functions of phagocytes at
distant sites. Upon parenteral infection with attenuated
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SL3261, resident macrophages release a systemic factor
that acts upon uninfected macrophages to condition them
to become less able to control the net growth rate of
the C5 bacteria. In fact, the accelerated growth of C5
coincides with continuous spread from infected to non-
infected cells, with spatial segregation from the sites of
persistence of SL3261 (unpublished data) and with a large
excess of uninfected cells in the tissues throughout the
infection.50,51
In search of a systemic mechanism that might be
responsible for the suppression of macrophage functions
we considered the possibility that the injection of the
attenuated SL3261 strain might induce an early endo-
toxin-dependent release of inflammatory cytokines fol-
lowed by a state of endotoxin tolerance.52 This would
prevent the host producing those key cytokines (e.g.
tumour necrosis factor-a and IFN-c) that are needed for
phagocyte recruitment and activation and for the control
of S. enterica in the tissues.21,28,37 We did not observe a
reduction in cytokine production nor in cytokine messen-
ger RNA expression in the animals undergoing double
infections (unpublished data). We investigated the possi-
bility that the release of immunosuppressant soluble fac-
tors could be responsible for the global downregulation of
phagocyte functions that resulted in the exacerbated
growth of the virulent C5 strain. We identified IL-10 as
one of the important mediators of the increase in net
growth rate of C5 induced by coadministration of inter-
mediate doses of SL3261. These findings are consistent
with the known cellular effects of IL-10, which include
reduced antibacterial functions of phagocytes (e.g.
impaired reactive oxygen intermediates, reactive nitrogen
intermediates, proinflammatory cytokine production and
phagocytosis).53–56 Neutralization of IL-10 also reduces
the net bacterial growth rate of Salmonella in vivo.57
The precise intracellular antibacterial functions that are
suppressed by IL-10 require further clarification. After the
initial blood clearance phase, bacterial killing by phago-
cytes is negligible in the first few days of growth of S. ent-
erica systemic infections in mice58,59 and therefore it is
likely that IL-10 acts by inhibiting the bacteriostatic func-
tions of infected phagocytes, resulting in acceleration of
the division of the virulent S. enterica strain.
In this study we have revealed for the first time the role
of MyD88 and TRIF in the early in vivo production of
IL-10 in response to live Salmonella infections.
The initial in vivo IL-10 production in response to
Salmonella is entirely dependent upon TLR4, which fur-
ther demonstrates the predominant role of TLR4 during
Salmonella infections.60,61 Also, no exacerbation of the
infection was seen in TLR4)/) mice, indicating the
requirement for this receptor in the IL-10-dependent
increase in disease severity that we observed in double
infections. In single infections, the numbers of the
C5 strain in the tissues of TLR4)/) mice were higher
compared to those in control animals. This might raise
the concern that bacterial growth in TLR4 mice has
already reached the ‘theoretical’ maximum of the system,
making it difficult to appreciate any further exacerbation
in a double infection. We are confident that this is not
the case given the fact that we routinely observe a much
faster progression of the disease in other experimental
conditions (e.g. in gp91)/) phox mice). Also, we were able
to detect a disease exacerbation in double infections in
MyD88)/) mice where single infections were already more
severe than in control animals.
The general picture that is emerging from several
studies indicates that several mechanisms and adaptor
molecules contribute to optimal production of IL-10 in
response to LPS stimulation. In fact, our results indicate
that S. enterica-induced IL-10 production requires func-
tional MyD88 and TRIF with maximal cytokine produc-
tion requiring the function of both adaptor molecules. A
recent publication by Boonstra et al.48 demonstrated that
both MyD88 and TRIF adaptors were required to regu-
late IL-10 production in response to LPS by BMDM
in vitro. Recently it has also been discovered that
TRIF-mediated, LPS-induced IL-10 production may be
secondarily upregulated through LPS-induced IFN-b
production.62 Interferon-b then binds to the type I IFN
receptor (IFNAR) to activate the JAK–STAT pathway
(janus kinase–signal transducer and activator of tran-
scription), which in turn leads to IL-10 production
through as yet unknown transcription factors. Each
adaptor can lead to IL-10 production independently of
the other but optimal induction in response to LPS
stimulation is only possible when there is interaction
between the two signalling arms. The relative contribu-
tion of IFN-b to in vivo production of IL-10 will be the
object of further studies.
The work described here provides proof of principle
that attenuated Salmonella strains can exacerbate the
growth of virulent strains acquired concurrently, although
this has yet to be proved using the oral route of infection.
This research may help inform procedures and safety
guidelines when using live vaccine strains in areas of the
world where typhoid fever is endemic and there is a
strong likelihood that individuals could become infected
with environmentally acquired strains during vaccination
programmes.
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